Nitric oxide signaling comes of age: 20 years and thriving

Cardiovascular Research

Volumn 75, Issue 2, 2007, Pages 207-209

  Lamas, Santiago ^a   Lowenstein, Charles J ^b   Michel, Thomas ^c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANOSINE TRIPHOSPHATASE; NITRATE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; SILDENAFIL;

CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR SYSTEM; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ERECTILE DYSFUNCTION; HUMAN; NITRATION; NITROSYLATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 34250709081     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.05.023     Document Type: Editorial

References (37)

1. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84 (1987) 9265-9269
2. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
3. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
4. Kimura H., Mittal C.K., and Murad F. Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase. Nature 257 (1975) 700-702
5. Palmer R.M., Ashton D.S., and Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333 (1988) 664-666
6. Dedon P.C., and Tannenbaum S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423 (2004) 12-22
7. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A 89 (1992) 7674-7677
8. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A 89 (1992) 444-448
9. Derakhshan B., Hao G., and Gross S.S. Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc Res 75 (2007) 210-219
10. Martinez-Ruiz A., and Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 75 (2007) 220-228
11. Stamler J.S., Lamas S., and Fang F.C. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106 (2001) 675-683
12. Raines K.W., Bonini M.G., and Campbell S.L. Nitric oxide cell signaling: S-nitrosation of Ras superfamily GTPases. Cardiovasc Res 75 (2007) 229-239
13. Lowenstein C.J. Nitric oxide regulation of protein trafficking in the cardiovascular system. Cardiovasc Res 75 (2007) 240-246
14. Selemidis S., Dusting G.J., Peshavariya H., Kemp-Harper B.K., and Drummond G.R. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res 75 (2007) 349-358
15. Hammoud L., Xiang F., Lu X., Brunner F., Leco K., and Feng Q. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting the tissue inhibitor of metalloproteinase-3 expression. Cardiovasc Res 75 (2007) 359-368
16. Marletta M.A. Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated?. Trends Biochem Sci 26 (2001) 519-521
17. Dudzinski D., and Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 75 (2007) 247-260
18. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
19. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
20. Zhang Q.J., Li Q.X., Zhang H.F., Zhang K.R., Guo W.Y., Wang H.C., et al. Swim training sensitizes myocardial response to insulin: role of Akt-dependent eNOS activation. Cardiovasc Res 75 (2007) 369-380
21. Mann G.E., Rowlands D.J., Li F.Y.L., de Winter P., and Siow R.C.M. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res 75 (2007) 261-274
22. Liu X.M., Peyton K.J., Ensenat D., Wang H., Hannink M., Alam J., et al. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res 75 (2007) 381-389
23. Brüne B., and Zhou J. Nitric oxide and superoxide: Interference with hypoxic signaling. Cardiovasc Res 75 (2007) 275-282
24. Brown G.C., and Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75 (2007) 283-290
25. Peluffo G., and Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 75 (2007) 291-302
26. Kandeel F.R., Koussa V.K., and Swerdloff R.S. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev 22 (2001) 342-388
27. Kass D.A., Takimoto E., Nagayama T., and Champion H.C. Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res 75 (2007) 303-314
28. Perez-Sala D., and Lamas S. Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid Redox Signal 3 (2001) 231-248
29. Klein T., Eltze M., Grebe T., Hatzelmann A., and Kömhoff M. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition. Cardiovasc Res 75 (2007) 390-397
30. Blanco-Rivero J., Marquez-Rodas I., Xavier F.E., Aras-Lopez R., Arroyo-Villa I., Ferrer M., et al. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway. Cardiovasc Res 75 (2007) 398-407
31. Seddon M., Shah A.M., and Casadei B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 75 (2007) 315-326
32. Geoghegan-Morphet N., Burger D., Lu X., Sathish V., Peng T., Sims S.M., et al. Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-a expression in cardiomyocytes. Cardiovasc Res 75 (2007) 408-416
33. Stühlinger M., Conci E., Haubner B., Schwaighofer J., Cooke J., Tsao P., et al. Asymmetric dimethylarginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc Res 75 (2007) 417-425
34. + via cGMP/PKG Signaling Pathway and Prevents Mitochondrial Oxidant Damage in Cardiomyocytes. Cardiovasc Res 75 (2007) 426-433
35. Dezfulian C., Raat N.J.H., Shiva S., and Gladwin M. Role of the anion nitrite in ischemia reperfusion cytoprotection and therapeutics. Cardiovasc Res 75 (2007) 327-338
36. Rogers S.C., Khalatbari A., Datta B.N., Ellery S., Paul V., Frenneaux M.P., et al. NO metabolite flux across the human coronary circulation. Cardiovasc Res 75 (2007) 434-441
37. Bloch K.D., Ichinose F., Roberts Jr. J.D., and Zapol W.M. Inhaled NO as a therapeutic agent. Cardiovasc Res 75 (2007) 339-348